All Issue

2024 Vol.5, Issue 4 Preview Page

Review article

31 December 2024. pp. 131-136
Abstract
Sorry, not available.
Click the PDF button.
References
1

Lokeshwar SD et al., A Systematic Review of Reported Ejaculatory Dysfunction in Clinical Trials Evaluating Minimally Invasive Treatment Modalities for BPH, Curr Urol Rep, 2020

10.1007/s11934-020-01012-y33104947
2

McConnell JD et al., The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia, N Engl J Med, 2003

3

Roehrborn CG et al., The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study, Eur Urol, 2010

10.1016/j.eururo.2009.09.03519825505
4

Vela-Navarrete R et al., The impact of medical therapy on surgery for benign prostatic hyperplasia: A study comparing changes in a decade (1992-2002), BJU Int, 2005

10.1111/j.1464-410X.2005.05735.x16225526
5

Marszalek M et al., Transurethral Resection of the Prostate, Eur Urol Suppl, 2009

10.1016/j.eursup.2009.02.003
6

McConnell JD. Benign Prostatic Hyperplasia: Diagnosis and Treatment; No. 94-0582; U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research: Rockville, MD, USA, 1994

7

Unger JM et al., Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial, J Natl Cancer Inst, 2016

10.1093/jnci/djw16827565902PMC5241895
8

Tacklind J et al., Finasteride for benign prostatic hyperplasia, Cochrane Database Syst Rev, 2010

10.1002/14651858.CD006015.pub2PMC3090655
9

Flanigan RC et al., 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A Department of Veterans Affairs cooperative study, J Urol, 1998

10.1097/00005392-199807000-00008
10

Izard J et al., Impact of medical therapy on transurethral resection of the prostate: Two decades of change, BJU Int, 2011

10.1016/j.juro.2010.02.2147
11

Mayer EK et al., Examining the 'gold standard': A comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes, BJU Int, 2012

10.1111/j.1464-410X.2012.11119.x22540956
12

Bulut S et al., Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia, Urol Int, 2015

10.1159/00036358125139617
13

Krambeck AE et al., Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting, BJU Int, 2012

10.1111/j.1464-410X.2012.10998.x22471348PMC3468668
14

Lin YH et al., Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction, BMC Geriatr, 2018

10.1186/s12877-018-0709-329338688PMC5771192
15

Thompson IM et al., The influence of finasteride on the development of prostate cancer, N Engl J Med, 2003

16

Thompson IM et al., Long-term survival of participants in the prostate cancer prevention trial, N Engl. J Med, 2013

10.1056/NEJMoa121593223944298PMC4141537
17

Ibrahim A et al., 18 Years of Holmium Laser Enucleation of the Prostate: A Single Center Experience, J Urol, 2019

10.1097/JU.000000000000028031009288
18

McVary KT et al., Rezum Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 4-Year Results from Randomized Controlled Study, Urology, 2019

10.1016/j.urology.2018.12.04130677455
19

Roehrborn CG et al., Five-year results of the prospective randomized controlled prostatic urethral L.I.F.T. study, Can J Urol, 2017

20

Gilling P et al., Water: A Double-Blind, Randomized, Controlled Trial of Aquablation((R)) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia, J Urol, 2018

10.1016/j.juro.2017.12.06529360529
21

DiSantostefano RL et al., An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia, BJU Int, 2006

10.1111/j.1464-410X.2005.06089.x16542339
22

Ahn HS et al., Long-term cost comparison between surgical and medical therapy for benign prostatic hyperplasia: A study using hospital billing data, BJU Int, 2019

10.1111/bju.14584
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 5
  • No :4
  • Pages :131-136